Normal view MARC view ISBD view

Targeted therapies: Selumetinib MEKing differences in NF1.

Hutchinson, Lisa

Targeted therapies: Selumetinib MEKing differences in NF1. [electronic resource] - Nature reviews. Clinical oncology 03 2017 - 140 p. digital

Publication Type: Journal Article; Comment

ISSN: 1759-4782

Standard No.: 10.1038/nrclinonc.2017.6 doi

Subjects--Topical Terms:
Benzimidazoles
Humans
MAP Kinase Kinase 2

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)